Startups
Check if you can get help with the cost of NHS prescriptions, NHS dental treatment, and more.
Overview
Location
United Kingdom, England, Newcastle upon Tyne
Employees
1001-5000
Founded date
2006
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 20, 2026 | Lumera to continue supporting targeted NHS Pension Scheme communications | Lumera to continue supporting targeted NHS Pension Scheme communications Thu, Aug 20, 2026 08:30 CET Report this content London, 20 August, 2026 – Lumera, a leading insurtech company dedicated to the digital transformation of the global Lif... |
| Oct 14, 2025 | Infosys Chosen by NHSBSA to Deliver a New Workforce Management Solution for the NHS in England and Wales | Next-Generation solution supports the NHS 10-year Health Plan and the mission to create a workforce that is fit for the future LONDON and BENGALURU, India, Oct. 14, 2025 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global... |
| Jul 10, 2025 | Britain can’t afford to pay the doctors’ Danegeld | Continued strike action is unsustainable and unfair to taxpayers and patients, given the UK’s financial constraints, ballooning pension liabilities, and already generous public investment in their training and benefits, says Maxwell Marlow ... |
| Aug 13, 2021 | Лучшие и необычные идеи бизнеса со всего мира | Лучшие и необычные идеи бизнеса со всего мира |
| Jun 14, 2021 | LUPIN LIMITED Lupin : receives UK marketing authorization for Luforbec® 100/6 µg pMDI, first branded generic alternative to Fostair® 100/6 µg pMDI for treatment of Asthma & COPD | Lupin receives UK marketing authorization for Luforbec® 100/6 µg pMDI, first branded generic alternative to Fostair® 100/6 µg pMDI for treatment of Asthma & COPD Mumbai, India | Slough, UK, June 14, 2021: Global pharma major, Lupin Limi... |
| Jun 1, 2021 | ADVANZ PHARMA : Nordic Capital Acquires Specialty Pharmaceutical Company ADVANZ PHARMA in Deal Worth ~$846 Million | The acquisition will bring significant investment and expertise to help fuel ADVANZ PHARMA's growth, with the potential to bring further cost-savings to the NHS and wider European healthcare systems while enhancing choice and access to crit... |
| Jun 16, 2020 | CryptoAM: Shines its spotlight on Cygnetise | The release of a commercially live product in 2018 saw Cygnetise gain its first paying customers. Since then, the product and technology has continually improved, driven by market demand whilst over-zealous ambitions have been prudently rei... |